Summary: NovoThelium won the 2nd annual Golden Ticket Pitch Competition, gaining mentorship and resources from Allergan Aesthetics and University Lab Partners to advance innovations in nipple reconstruction post-mastectomy.
Key Takeaways
- NovoThelium won the Golden Ticket Pitch Competition, gaining crucial resources and mentorship for their innovations in nipple reconstruction after mastectomy.
- The competition, organized by University Lab Partners and sponsored by Allergan Aesthetics, provides startups with free lab space, equipment, and industry mentorship.
- Allergan Aesthetics continues to support early science and regenerative technologies through initiatives like the Golden Ticket competition.
—————————————————————————————————————————————
NovoThelium was selected as the winner of the 2nd annual Golden Ticket Pitch Competition for aesthetic startups, organized by University Lab Partners (ULP) and sponsored by Allergan Aesthetics.
Five finalists presented their aesthetic technologies to a panel of judges, including Charlie Hee, PhD, vice president of devices at Allergan Aesthetics; Sherly Soleiman, MD, founder and lead injector at Cosmetic Injectable Center; and Michael Hill, managing director of Capital Markets at Octane.
Lauren Cornell, PhD, co-founder and CEO of Novothelium shared, “Winning the Golden Ticket from University Lab Partners and Allergan Aesthetics will provide NovoThelium with vital resources and mentorship, enabling us to enhance women’s healthcare and pioneer innovations in nipple reconstruction post-mastectomy.”
Boosting Aesthetic Medicine Startups
The Golden Ticket competition accelerates the research and development of startup aesthetics enterprises by offering the winner one year of free lab space at ULP, complete with advanced research equipment, professional support staff, conference rooms, and a collaborative community. In addition, the winner gains access to industry mentorship, including from leaders at Allergan Aesthetics.
“Allergan Aesthetics is honored and inspired to support Novothelium as part of our efforts to accelerate the growth and development of entrepreneurs and researchers in aesthetic medicine,” says Darin Messina, PhD, senior vice president of aesthetics R&D and AbbVie. “The Golden Ticket competition exemplifies our continued investment in early science and regenerative technologies and defining what’s next for the aesthetics industry.”
